Compare IDEXX Laboratories, Inc. (IDXX) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? IDEXX Laboratories, Inc. trades at $551.53 (market cap $44.48B), while Direxion Daily FTSE China Bull 3x Shares trades at $28. Which is the better fit depends on your goals.
| IDXX | YINN | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $56.62 |
52-Week Low | $520.87 | $21.45 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
YINN (Direxion Daily FTSE China Bull 3x ETF) trades at $28.89, up 7.84% with a bullish technical signal. The leveraged ETF structure amplifies exposure to Chinese equities, which face mixed sentiment amid economic stabilization efforts and US-China tensions. Moving averages show bullish momentum while oscillators remain neutral, with key resistance at $27.
Outlook remains volatile given YINN's 3x leverage structure and China's economic crosscurrents. Investment opportunity exists for tactical traders betting on China's infrastructure and AI stimulus, but risks include geopolitical friction and leveraged decay. The fund's performance hinges on Beijing's policy effectiveness versus US restrictions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
